TARDBP and Lewy body dementia: Several fluid biomarkers specific to core pathologic proteins of other neurodegenerative disorders, such as TDP-43 and α-synuclein protein levels, have emerged as potential biomarkers in frontotemporal dementia and Lewy body dementia/Parkinson’s disease dementia, respectively32,33.